Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus

Lupus

Volumn 24, Issue 6, 2015, Pages 582-587

  Kazemipour, N ^a,b   Qazizadeh, H ^b   Sepehrimanesh, M ^c   Salimi, S ^d  

^a SHIRAZ UNIVERSITY   (Iran)

^b UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

haptoglobin; MALDI TOF TOF MS; serum proteome; Systemic lupus erythematosus; transthyretin

Indexed keywords

ALBUMIN; APOLIPOPROTEIN; BIOLOGICAL MARKER; HAPTOGLOBIN; KERATIN; PREALBUMIN; PROTEOME; PROTHROMBIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; FEMALE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEOMICS; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TWO DIMENSIONAL GEL ELECTROPHORESIS; BLOOD; GENETIC POLYMORPHISM; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROCEDURES;

ADULT; BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HAPTOGLOBINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, GENETIC; PREALBUMIN; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84928016033     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314558860     Document Type: Article

References (30)

1. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006 ; 25: 383-392
2. Wallace DJ The clinical presentation of systemic lupus erythematosus. In: Wallace DJ Hahn BH, (eds), Dubois' lupus erythematosus. 5th ed. Baltimore: Lippincott Wilkins & Wilkins, 1997, pp. 627-634.
3. Bauer JW, Baechler EC, Petri M, et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Medicine. 2006 ; 3: e491
4. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008 ; 358: 929-939
5. Prokunina L, Castillejo-Lopez C, Oberg F, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nature Genet. 2002 ; 32: 666-669
6. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immunity. 2003 ; 4: 177-186
7. Dai Y, Huang YS, Tang M, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus. 2007 ; 16: 939-946
8. Kalenka A, Feldmann RE, Otero K, Maurer MH, Waschke KF, Fiedler F. Changes in the serum proteome of patients with sepsis and septic shock. Anesthes Analges. 2006 ; 103: 1522-1526
9. Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics. 2006 ; 6: 6326-6353
10. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics. 2003 ; 2: 1096-1103
11. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254
12. Ahmed N, Barker G, Oliva K, et al. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics. 2003 ; 3: 1980-1987
13. Kazemipour N, Condemine G, Hugouvieux-Cotte-Pattat N. The secretome of the plant pathogenic bacterium Erwinia chrysanthemi. Proteomics. 2004 ; 4: 3177-3186
14. Beutler E, Gelbart T, Lee P. Haptoglobin polymorphism and iron homeostasis. Clin Chem. 2002 ; 48: 2232-2235
15. Ahmed N, Barker G, Oliva KT, et al. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer. 2004 ; 91: 129-140
16. Pavon EJ, Munoz P, Lario A, et al. Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin α2 polypeptide chains over the α1 isoforms. Proteomics. 2006 ; 6: S282-S292
17. Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta. 2004 ; 345: 35-42
18. Breslow JL, Ross D, McPherson J, et al. Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc Natl Acad Sci U S A. 1982 ; 79: 6861-6865
19. Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ. Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: Implications for drug discovery. Nat Rev Drug Discov. 2008 ; 7: 84-99
20. Wilhelm AJ, Zabalawi M, Grayson JM, et al. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol. 2009 ; 29: 843-849
21. Bresnihan B, Gogarty M, FitzGerald O, Dayer JM, Burger D. Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: A control mechanism of cytokine production?. Arthritis Res Ther. 2004 ; 6: 563-566
22. Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimm Rev. 2002 ; 1: 233-237
23. Hyka N, Dayer JM, Modoux C, et al. Apolipoprotein A-I inhibits the production of interleukin-1{beta} and tumor necrosis factor-{alpha} by blocking contact-mediated activation of monocytes by T lymphocytes. Blood. 2001 ; 97: 2381-2389
24. McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 ; 54: 2541-2549
25. Nelson DL, Lehninger AL, Cox MM. Lehninger principles of biochemistry, 5th ed. New York, USA: Macmillan, 2008. pp. 1294-1294.
26. Gao WM, Kuick R, Orchekowski RP, et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer. 2005 ; 5: 110
27. Gericke B, Raila J, Sehouli J, et al. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. BMC Cancer. 2005 ; 5: 133
28. Zhang Z, Bast RCJ, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004 ; 64: 5882-5890
29. Rana A, Minz RW, Aggarwal R, et al. A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS-A pilot study. Pediatr Rheumatol. 2012 ; 10: 24-32
30. Korte EA, Gaffney PM, Powell DW. Contributions of mass spectrometry-based proteomics to defi ning cellular mechanisms and diagnostic markers for systemic lupus erythematosus. Arthritis Res Ther. 2012 ; 14: 204-214